Document is current
Any future updates will be listed below
-
Authors
Sklenar, Marek
Borecka, Silvia
Varga, Lukas
Bernardinelli, Emanuele
Stanik, Juraj
Skopkova, Martina
Sabo, Miroslav
Ugorova, Diana
Dossena, Silvia
Gasperikova, Daniela https://orcid.org/0000-0002-5725-6424
-
Funding
Funding for this research was provided by:
Doktogrant Slovenska akademia vied (APP0485)
Agentúra na Podporu Výskumu a Vývoja (APVV-20-0236, APVV-20-0236, APVV-20-0236, APVV-20-0236, APVV-20-0236, APVV-20-0236, APVV-20-0236)
Vedecka grantova agentura MSVVaM SR a SAV (VEGA 1/0572/21, VEGA 1/0572/21, VEGA 1/0572/21, VEGA 1/0659/22, VEGA 1/0572/21)
Structural funds Slovakia (ITMS 313010AFG5, ITMS 313010AFG5)
- License Information
-
More Information
Article History
Received: 26 March 2025
Accepted: 13 May 2025
First Online: 27 May 2025
Declarations
:
: All individuals or their legal representatives (in subjects under 18 years of age) signed informed consent to genetic testing. The study was conducted in accordance with the Declaration of Helsinki and the Guidelines for Good Pharmacoepidemiology Practice. The study was reviewed and approved by institutional review board/ethics committee– the Ethics Committees of the University Hospital in Bratislava (No. 33/26102010, PI: Milan Profant) and the National Institute of Children’s Diseases in Bratislava (No.14/06/2005, PI: Lubomir Barak), before the study began.
: Not applicable.
: The authors declare no competing interests.
